BASG and companies

News

Current issue of “RMS NEWS”

messages in brief | 31/03/2023

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Current issue of “RMS NEWS”

messages in brief | 30/09/2022

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Current issue of “RMS NEWS”

messages in brief | 30/06/2022

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Current issue of “RMS NEWS”

messages in brief | 31/03/2022

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Current issue of “RMS NEWS”

messages in brief | 31/01/2022

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Information

The new Veterinary Medicinal Products Regulation is to be applied as of 28.01.2022, further information can be found here:

The new Veterinary Medicinal Products Regulation is to be applied as of 28.01.2022, further information can be found here:

Reporting to BASG

Reporting to BASG

The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.

BREXIT

BREXIT

The transition period ended on 31.12.2020. Marketing authorisation holders are reminded to submit any outstanding amendments without delay.

Clinical Trials

Clinical Trials

The BASG authorises and monitors the conduct of clinical trials with medicinal products and medical devices.

Austrian Pharmacopoeia

Austrian Pharmacopoeia

The Austrian Pharmacopoeia (ÖAB) is a national addendum to the European Pharmacopoeia and is currently being revised by the ÖAB Commission.